Ranson criteria for acute pancreatitis is a widely validated, multi-parameter clinical scoring system designed to estimate disease severity, anticipate systemic and local complications, and prognosticate mortality in patients experiencing acute inflammation of the pancreas1,3. Originally developed by John H.C. Ranson and colleagues in 1974, the scoring model separates variables into two distinct chronological phases: those assessed immediately at the time of hospital admission and those evaluated over the subsequent 48 hours1,2. By quantifying physiological derangements, metabolic stress, and end-organ shifts, the Ranson scoring system provides clinicians with an objective metric to guide triage toward intermediate or intensive care units, dictate the necessity of advanced imaging, and monitor therapeutic efficacy during initial resuscitation3.

Etiology & Risk Factors

  • Biliary Lithiasis (Gallstones): Accounting for approximately 40% to 50% of all acute pancreatitis cases worldwide, microlithiasis or larger gallstones obstruct the ampulla of Vater, causing transient or sustained biliopancreatic duct hypertension and subsequent acinar injury1.
  • Alcohol Abuse: Responsible for 30% to 35% of cases; ethanol metabolites directly trigger intracellular trypsinogen activation, oxidative stress, and premature lysosomal-zymogen colocalization within pancreatic acinar cells.
  • Hypertriglyceridemia: Serum triglyceride levels exceeding 1,000 mg/dL (11.3 mmol/L) hydrolyze into toxic free fatty acids via pancreatic lipase, causing capillary thrombosis, ischemia, and parenchymal acidemia.
  • Iatrogenic & Procedural: Endoscopic retrograde cholangiopancreatography (ERCP) is the leading iatrogenic cause, precipitating pancreatitis in up to 5% to 10% of unselected procedures due to mechanical manipulation, hydrostatic contrast injection, or thermal sphincter trauma.
  • Anatomic & Structural Anomalies: Pancreas divisum, annular pancreas, choledochoceles, and congenital ductal strictures predispose patients to recurrent outflow obstruction and localized ductal hypertension.
  • Metabolic & Endocrine Disorders: Hypercalcemia (most commonly secondary to primary hyperparathyroidism) drives intracellular calcium overload, aberrantly signaling zymogen activation.
  • Pharmacological Agents: Numerous prescription medications induce drug-induced acute pancreatitis via idiosyncratic or hypersensitivity mechanisms, including azathioprine, 6-mercaptopurine, valproic acid, thiazide diuretics, estrogens, and certain antiretroviral regimens.
  • Infectious & Toxin-Mediated: Mumps virus, coxsackievirus, cytomegalovirus, Epstein-Barr virus, and scorpion envenomation (e.g., Tityus trinitatis) directly damage pancreatic duct epithelium and acinar architecture.

Pathophysiology

The pathophysiological continuum of acute pancreatitis is initiated by the premature intracellular activation of trypsinogen into active trypsin within pancreatic acinar cells, bypassing normal protective regulatory pathways such as the cleavage inhibition of mesotrypsin and serine protease inhibitor Kazal type 1 (SPINK1). Once active trypsin accumulates, it unleashes a destructive enzymatic cascade, converting inactive pro-enzymes—including chymotrypsinogen, proelastase, and phospholipase A2—into their active forms. This enzymatic assault results in direct cellular auto-digestion, microvascular endothelial injury, interstitial edema, fat necrosis, and focal parenchymal hemorrhage. The localized tissue destruction provokes an intense acute inflammatory response, recruiting neutrophils and macrophages that release pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-$\alpha$), interleukin-1 beta (IL-1$\beta$), and interleukin-6 (IL-6). These systemic inflammatory mediators increase vascular permeability, precipitating third-spacing of intravascular fluid, profound systemic hypotension, acute respiratory distress syndrome (ARDS), and systemic inflammatory response syndrome (SIRS). If unmitigated, persistent hypoperfusion culminates in multiorgan dysfunction syndrome (MODS) and extensive pancreatic necrosis.

Ranson criteria for acute pancreatitis — Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Premature activation of pancreatic zymogens within acinar cells via gallstones or alcohol. 2 Cellular / Pathophysiological Cascade Local auto-digestion of pancreatic parenchyma leading to severe systemic inflammatory response syndrome (SIRS). 3 Target Organ / Structural Change Edema, hemorrhage, and pancreatic or peripancreatic necrosis. 4 Hallmark Clinical & Diagnostic Manifestation Severe epigastric pain radiating to the back with elevated serum lipase greater than three times the upper limit of normal. 5 Complications if Untreated & Therapeutic Target Multi-organ failure and sepsis managed via aggressive fluid resuscitation and prognostic risk stratification.

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients classically present with the abrupt onset of severe, steady, boring epigastric pain that characteristically radiates straight through to the mid-back in a band-like distribution. The pain is frequently ameliorated by sitting up and leaning forward. It is invariably accompanied by intractable nausea, recurrent non-bilious vomiting that fails to relieve the pain, and profound abdominal distention.
  • Physical Examination & Named Clinical Signs:
    • General Appearance: Patients appear acutely distressed, diaphoretic, anxious, and tachycardic, frequently exhibiting low-grade or high-grade fever secondary to systemic inflammation.
    • Abdominal Inspection & Palpation: Abdominal examination reveals localized or generalized epigastric tenderness with guarding and abdominal distention. Bowel sounds are typically hypoactive or entirely absent due to a concomitant paralytic ileus secondary to retroperitoneal inflammation.
    • Grey Turner Sign: Bluish discoloration of the flanks resulting from retroperitoneal tracking of hemorrhagic exudate, indicative of severe necrotizing pancreatitis (typically appearing 24 to 48 hours after symptom onset).
    • Cullen Sign: Superficial edema and bruising around the subcutaneous fatty umbilical ring caused by tracking of hemoperitoneum along the falciform ligament.
    • Fox Sign: Ecchymosis and discoloration over the inguinal ligament, reflecting tracking of retroperitoneal hemorrhage and enzymatic fat necrosis down the psoas muscle sheath.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationContrast-Enhanced Computed Tomography (CECT) of the abdomen and pelvis demonstrating non-enhancing areas of pancreatic parenchyma (necrosis) or peripancreatic fluid collections; deferred until 72–96 hours post-admission to avoid underestimating the ultimate extent of pancreatic necrosis.
Laboratory PanelSerum lipase elevated greater than three times the upper limit of normal (typically peaks within 24 hours and remains elevated for 8–14 days; superior specificity compared to amylase). Complete blood count demonstrating hemoconcentration (hematocrit > 44% indicating significant intravascular volume depletion) and leukocytosis (WBC > 16,000/$\mu$L). Comprehensive metabolic panel revealing elevated blood urea nitrogen (BUN > 25 mg/dL), elevated serum creatinine, hyperglycemia secondary to beta-cell destruction and stress hormones, and hypocalcemia due to saponification of calcium in areas of fat necrosis. Liver function tests revealing obstructive patterns (elevated total bilirubin, alkaline phosphatase, and ALT > 150 IU/L strongly predictive of gallstone etiology). Serum triglycerides exceeding 1,000 mg/dL when hyperlipidemia is the underlying culprit.
Imaging / Radiology (X-ray, US, CT, MRI)Abdominal ultrasound performed primarily on admission to evaluate for cholelithiasis and biliary ductal dilation as the underlying etiology. Chest radiography showing bilateral pleural effusions (predominantly left-sided), basilar atelectasis, or elevated hemidiaphragms. Plain abdominal radiography demonstrating the "sentinel loop" sign (localized ileus of a jejunal loop in the upper left quadrant) or the "colon cut-off" sign (abrupt cessation of colonic gas at the splenic flexure). Magnetic Resonance Cholangiopancreatography (MRCP) utilized for non-invasive evaluation of biliary ductal stones or structural ductal anomalies when CECT is contraindicated or equivocal.
ECG / Histopathology / ProceduralElectrocardiogram (ECG) mandatory to exclude acute myocardial infarction, which can closely mimic the epigastric pain presentation of severe pancreatitis. Endoscopic Ultrasound (EUS) utilized post-recovery to identify occult microlithiasis, biliary sludge, or early chronic pancreatitis features. Histopathological evaluation (if surgical specimen or autopsy obtained) confirming interstitial edema, acinar cell necrosis, fat saponification, and polymorphonuclear leukocytic infiltration.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Ranson Criteria: At Admission (Age > 55)Patient age greater than 55 years (1 point). Associated with decreased physiological reserve and higher baseline comorbidity burden.
Ranson Criteria: At Admission (White Blood Cell Count)Initial leukocyte count greater than 16,000/$\mu$L (1 point). Reflects intense systemic inflammatory response syndrome (SIRS).
Ranson Criteria: At Admission (Blood Glucose)Initial serum glucose greater than 200 mg/dL (11.1 mmol/L) (1 point). Indicates stress hyperglycemia or underlying pancreatic endocrine dysfunction.
Ranson Criteria: At Admission (Serum LDH)Serum lactic dehydrogenase (LDH) greater than 350 IU/L (1 point). Signifies cellular destruction and tissue ischemia.
Ranson Criteria: At Admission (Serum AST)Serum aspartate aminotransferase (AST) greater than 250 IU/L (1 point). Reflects acute hepatocellular injury or severe biliary ductal pressure.
Ranson Criteria: 48 Hours (Hematocrit Drop)Fall in hematocrit greater than 10% from baseline admission value (1 point). Directly indicates ongoing intravascular volume loss, retroperitoneal hemorrhage, and third-spacing.
Ranson Criteria: 48 Hours (BUN Rise)Rise in blood urea nitrogen (BUN) greater than 5 mg/dL despite adequate IV fluid resuscitation (1 point). Signifies prerenal azotemia, renal hypoperfusion, and inadequate volume repletion.
Ranson Criteria: 48 Hours (Serum Calcium)Serum calcium level less than 8.0 mg/dL (2.0 mmol/L) (1 point). Caused by calcium binding to free fatty acids in areas of saponification and hypoalbuminemia.
Ranson Criteria: 48 Hours (Arterial pO_2)Arterial oxygen partial pressure (pO_2) less than 60 mmHg (1 point). Reflects acute pulmonary insufficiency, ARDS, or microatelectasis.
Ranson Criteria: 48 Hours (Base Deficit)Calculated base deficit greater than 4 mEq/L (1 point). Indicates systemic metabolic acidosis and systemic hypoperfusion.
Ranson Criteria: 48 Hours (Fluid Sequestration)Estimated fluid sequestration greater than 6 liters (1 point). Reflects massive third-space fluid loss into the retroperitoneum and peritoneal cavity.
Ranson Scoring Interpretation & Mortality RiskScore 0–2: Mild acute pancreatitis (predicted mortality < 1%). Score 3–4: Moderate acute pancreatitis (predicted mortality ~15%). Score 5–6: Severe acute pancreatitis (predicted mortality ~40%). Score 7–11: Critical acute pancreatitis (predicted mortality > 100% or extreme morbidity).

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Perforated Peptic UlcerPresents with sudden, excruciating, generalized abdominal pain and board-like rigidity. Upright chest or abdominal radiography demonstrates free intraperitoneal air under the diaphragm (pneumoperitoneum). Serum lipase is typically normal or only mildly elevated.
Acute Cholecystitis & Biliary ColicPain localizes predominantly to the right upper quadrant with a positive Murphy sign. Ultrasound demonstrates gallbladder wall thickening (> 3 mm), pericholecystic fluid, and sonographic Murphy sign, with normal or minimally elevated lipase levels.
Acute Intestinal ObstructionFeatures colicky abdominal pain, absolute constipation, high-pitched or tinkling bowel sounds, and visible peristalsis. Abdominal CT or plain films reveal dilated loops of bowel with multiple air-fluid levels and a clear transition point.
Acute Mesenteric IschemiaCharacterized by severe, disproportionate abdominal pain out of proportion to physical examination findings. Often occurs in patients with atrial fibrillation or atherosclerotic vascular disease. Contrast-enhanced CT angiography demonstrates filling defects in the superior mesenteric artery or vein.
Acute Myocardial InfarctionInferior wall myocardial infarctions frequently present with epigastric pain, nausea, and vomiting that can mimic acute pancreatitis. Distinguished by diagnostic 12-lead ECG findings (ST-segment elevations in leads II, III, aVF) and serial cardiac biomarker elevations (troponin I or T).

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Continuous cardiorespiratory monitoring, pulse oximetry, and placement of an indwelling urinary catheter to strictly monitor urine output (target > 0.5 mL/kg/h). Immediate correction of electrolyte abnormalities, specifically hypokalemia and hypomagnesemia.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing):
    • Fluid Resuscitation: Aggressive goal-directed crystalloid resuscitation utilizing lactated Ringer's solution administered at 10 to 20 mL/kg IV bolus followed by 3 mL/kg/h for the first 24 to 48 hours, adjusted continuously based on heart rate (< 100 bpm), mean arterial pressure (> 65 mmHg), and urine output. Avoid normal saline to prevent hyperchloremic metabolic acidosis.
    • Analgesia: Intravenous opioid administration for severe pain control. Hydromorphone administered at 0.5 to 1.5 mg IV every 3 to 4 hours PRN or Fentanyl administered at 50 to 100 mcg IV every 1 to 2 hours PRN. (Morphine was historically avoided due to theoretical concerns of sphincter of Oddi spasm, though clinical evidence supports its safety).
    • Nutritional Support: Early enteral nutrition initiated within 24 to 48 hours of admission via a nasojejunal or nasogastric tube with a low-fat elemental or polymeric formula to maintain gut mucosal integrity and prevent bacterial translocation. Total parenteral nutrition (TPN) is strictly reserved for patients who cannot tolerate or fail enteral feeding trials.
    • Antibiotic Stewardship: Prophylactic antibiotics are not routinely recommended for sterile acute pancreatitis. Reserved strictly for confirmed infected pancreatic necrosis or extrapancreatic infectious sources (e.g., cholangitis, pneumonia, urinary tract infection) utilizing broad-spectrum agents such as Imipenem-cilastatin administered at 500 mg IV every 6 hours or Meropenem administered at 1 g IV every 8 hours.
  • Surgical / Interventional Indications:
    • Biliary Decompression: Urgent diagnostic and therapeutic ERCP performed within 24 hours of admission for patients presenting with acute pancreatitis complicated by acute cholangitis or progressive biliary obstruction.
    • Interventional Radiology / Step-Up Approach: Minimally invasive percutaneous catheter drainage or endoscopic ultrasound (EUS)-guided transmural drainage for symptomatic walled-off pancreatic necrosis or infected fluid collections, delaying open surgical necrosectomy whenever clinically feasible.

Complications & Prognosis

  • Local Complications:
    • Acute Peripancreatic Fluid Collections: Occur within the first 4 weeks, located within or outside the pancreatic parenchyma, lacking a defined fibrous capsule.
    • Pancreatic Pseudocyst: Encapsulated collection of pancreatic juice with a well-defined inflammatory wall, occurring more than 4 weeks after the onset of interstitial edematous pancreatitis.
    • Walled-Off Necrosis (WON): Mature, encapsulated collection of pancreatic and/or peripancreatic necrotic tissue with a defined inflammatory wall, typically developing after 4 weeks.
  • Systemic Complications:
    • Pulmonary: Acute Respiratory Distress Syndrome (ARDS), pleural effusions, atelectasis, and pneumonia.
    • Cardiovascular: Hypovolemic shock, cardiogenic collapse, pericardial effusion, and sudden cardiac arrest.
    • Renal: Acute tubular necrosis (ATN) secondary to prolonged hypotension and prerenal azotemia.
    • Hematologic: Disseminated Intravascular Coagulation (DIC) driven by systemic release of activated pancreatic enzymes and tissue factor.
  • Prognosis & Mortality Data: The overall mortality rate for mild acute pancreatitis is less than 1%. However, in severe acute pancreatitis with persistent organ failure and infected necrosis, mortality rates escalate dramatically to 20% to 30%. The Ranson score remains a robust, validated predictor of these adverse outcomes, where scores exceeding 3 mandate immediate admission to a monitored high-dependency or intensive care unit setting.